Difficulty: Medium
Average Score: 67%
Practice
A pregnant adolescent tells the nurse she is taking isotretinoin (Accutane). Which statement is correct?
Correct answer
A
Rationale
In this scenario, option A is the correct answer because isotretinoin (Accutane) is indeed teratogenic, meaning it can cause severe birth defects and major fetal malformations if taken during pregnancy. As an educator, it is crucial to emphasize to students the importance of understanding the teratogenic effects of certain medications on fetal development.
Option A is correct because it highlights the immediate need for the pregnant adolescent to stop taking isotretinoin to prevent harm to the developing fetus. It is vital for students to grasp the gravity of the situation and the potential lifelong impact that teratogenic substances can have on fetal health. This question serves as a reminder of the responsibility healthcare providers have in educating pregnant individuals about medications that can pose risks during pregnancy.
Options B, C, and D are incorrect as they do not provide any relevant information or guidance regarding the teratogenic effects of isotretinoin. This highlights the importance of accurate knowledge and understanding when counseling pregnant individuals on medication safety.
Educationally, this question reinforces the significance of thorough medication assessment and counseling for pregnant clients. It underscores the need for healthcare professionals to stay informed about teratogenic risks and to effectively communicate this information to patients to ensure the best possible outcomes for both the pregnant individual and the developing fetus.
Option A is correct because it highlights the immediate need for the pregnant adolescent to stop taking isotretinoin to prevent harm to the developing fetus. It is vital for students to grasp the gravity of the situation and the potential lifelong impact that teratogenic substances can have on fetal health. This question serves as a reminder of the responsibility healthcare providers have in educating pregnant individuals about medications that can pose risks during pregnancy.
Options B, C, and D are incorrect as they do not provide any relevant information or guidance regarding the teratogenic effects of isotretinoin. This highlights the importance of accurate knowledge and understanding when counseling pregnant individuals on medication safety.
Educationally, this question reinforces the significance of thorough medication assessment and counseling for pregnant clients. It underscores the need for healthcare professionals to stay informed about teratogenic risks and to effectively communicate this information to patients to ensure the best possible outcomes for both the pregnant individual and the developing fetus.